Epigenetics Market Proliferating at a 12.9 % CAGR by 2023, Cancer Management to Boost the Global Epigenetics Industry Growth

Global Epigenetics Market Information; by Instruments (NGS, spectrometer, PCR, software solutions and others), by Consumables (kit, enzymes, reagent), by Application (oncology, developmental biology, drug discovery, cardiology, immunology), by Technology (methylation, histone modification)

Pune, India - October 4, 2019 /MarketersMedia/ —

Market Insights

In the latest report published by Market Research Future (MRFR) on the global epigenetics market it states that the market is expected to garner a 12.9 % compound annual growth rate during 2019-2023 and achieve a substantial market size by 2023 end.

Technical advancement, like development of protein, DNA, and RNA modifier enzymes which are helping in reducing the sequencing cost and time. It is also playing a significant role in designing targeted therapy and personalized medicine. The proliferation of the healthcare industry and the presence of reputed biotechnological firm are gaining traction for investment in research and development activities. Governments, across the world, are funding for epigenetics studies involving both cancer and non-oncology disease management. These are the market drivers envisaged to experience high growth in the emerging epigenetics market. On the other side, the major restraint, predicted by MRFR, on the global epigenetics market is the high cost involved in manufacturing, installation, and maintaining the epigenetics instruments.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6161

Segmental Overview

The segmental study of the global epigenetics market by MRFR offers a vivid market scenario. The market study has been segmented by instruments, consumables, applications, technology, and end users.

On the basis of instruments, the global epigenetics market is segmented into NGS, spectrometer, PCR, software solutions, and others.

On the basis of consumables, the global epigenetics market is segmented into kit, enzymes, reagent, and others.

On the basis of application, the global epigenetics market is segmented into oncology, developmental biology, drug discovery, cardiology, immunology, and others.

On the basis of technology, the global epigenetics market is segmented into methylation, histone modification, and others.

On the basis of end users, the market is segmented into academia and research, pharmaceutical and biotechnology industry and others.

Regional Analysis

North America, Europe, Asia Pacific Middle East and Africa, and Rest of the World (RoW) are the regions accounted by MRFR for demographic analysis of the epigenetics market.

The North American epigenetics market is anticipated to grow with the highest compound annual growth rate during the forecast period of 2016-2023. The existence of large biotechnology sectors coupled with advanced medical facilities is gaining traction for key players operating in the market to invest in research and development activities. Moreover, an increase in the prevalence of cancer among the population is urging the need for enhanced diagnostic techniques. This is another factor likely to drive the regional market expansion. Programs supporting raise for common funds in the US are expected to create a positive impact on the epigenetic market growth.

Cognizance of early diagnosis, increased investment in clinical research, and rise in disposable income in emerging economies like India and China, in the Asia Pacific region are the components which are predicted to cause epigenetic market growth escalation in the region.

Intensified research and developmental activities in Europe to envisage the regional epigenetic market. Germany, UK, and France are the countries predicted to follow the market size lead, North America. The Middle East and African epigenetic market to exhibit growth lag due to hindrance in the industrialization attributed to the impecunious economy of the regions.

Key Players

Bio-Rad (US), Illumina (US), QIAGEN (Netherlands), Thermo Fisher (US), Active Motif (US), Diagenode (Belgium), Agilent (US), Merck Millipore (US), Abcam (UK), New England Biolabs (US), PerkinElmer (US), Zymo Research (US) are some important companies listed by MRFR.

Industry News

April 2019: The merger of Greenwood Diagnostic Laboratories and London Health Sciences Centre resulted in innovating EpiSign. It is a blood test designed to detect epigenetic changes in patients.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/epigenetics-market-6161

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/epigenetics-market-6161

Source URL: https://marketersmedia.com/epigenetics-market-proliferating-at-a-129-cagr-by-2023-cancer-management-to-boost-the-global-epigenetics-industry-growth/88925667

Source: MarketersMedia

Release ID: 88925667